Daiwa Securities Group Inc. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4
-20.0%
5280.0%0.00%
Q2 2023$5
-16.7%
5280.0%0.00%
Q1 2023$6
+200.0%
5280.0%0.00%
Q4 2022$2
-100.0%
5280.0%0.00%
Q3 2022$4,000
-20.0%
5280.0%0.00%
Q2 2022$5,0000.0%528
+39.7%
0.00%
Q1 2022$5,000
-44.4%
3780.0%0.00%
Q4 2021$9,000
-10.0%
378
-14.1%
0.00%
Q3 2021$10,000
+233.3%
440
+84.9%
0.00%
Q2 2021$3,0000.0%2380.0%0.00%
Q1 2021$3,0000.0%2380.0%0.00%
Q4 2020$3,000
-66.7%
238
-62.9%
0.00%
Q3 2020$9,0000.0%642
+7.7%
0.00%
Q2 2020$9,0000.0%5960.0%0.00%
Q1 2020$9,000
-18.2%
596
+12.0%
0.00%
Q4 2019$11,000
+266.7%
532
-7.8%
0.00%
Q3 2019$3,000
-25.0%
5770.0%0.00%
Q2 2019$4,000
+33.3%
577
+24.4%
0.00%
Q1 2019$3,0000.0%4640.0%0.00%
Q4 2018$3,0000.0%4640.0%0.00%
Q3 2018$3,0000.0%4640.0%0.00%
Q2 2018$3,000
+50.0%
4640.0%0.00%
Q1 2018$2,0004640.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders